HomeAI · summaries
Storia in 3 fonti
Anticoagulation benefits patients with atrial fibrillation, intermediate stroke risk
MUNICH — In patients with atrial fibrillation and intermediate risk for stroke, direct oral anticoagulants were linked to reduced risk for death, stroke and major bleeding compared with no anticoagulation, researchers reported. The SINGLE-AF trial, conducted at 18 sites in South Korea, was presented at the European Society of Cardiology Congress and simultaneously published in The New
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
Anticoagulation benefits patients with atrial fibrillation, intermediate stroke risk
MUNICH — In patients with atrial fibrillation and intermediate risk for stroke, direct oral anticoagulants were linked to reduced risk for death, stroke and major bleeding…
- ·
medpagetoday.com
First Major Trial Win for Contemporary DOACs in Lower-Risk Afib
SINGLE-AF trial shows cardiovascular protection without unacceptable bleeding
